(Q36763727)

16 August 2017

Rates and cost of hospitalization before and after initiation of antiretroviral therapy in urban and rural settings in South Africa (English)

1 reference

16 August 2017

0 references

anti-retroviral agent

0 references

0 references

1 reference

Alana T Brennan

2

0 references

Gesine Meyer-Rath

Gesine Meyer-Rath

1

0 references

Matthew Patrick Fox

Matthew P Fox

3

0 references

Sydney Rosen

Sydney Rosen

7

0 references

Neil A Martinson

8

Neil Martinson

1 reference

16 August 2017

Tebogo Modisenyane

4

1 reference

16 August 2017

Nkeko Tshabangu

5

1 reference

16 August 2017

Lerato Mohapi

6

1 reference

16 August 2017

language of work or name

English

0 references

publication date

1 March 2013

1 reference

Journal of Acquired Immune Deficiency Syndromes

16 August 2017

1 reference

16 August 2017

62

1 reference

16 August 2017

3

1 reference

16 August 2017

322-328

1 reference

Body mass index and risk of tuberculosis and death

16 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3625673

Early severe morbidity and resource utilization in South African adults on antiretroviral therapy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3625673

Early and late direct costs in a Southern African antiretroviral treatment programme: a retrospective cohort analysis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3625673

Tuberculosis-associated immune reconstitution inflammatory syndrome and unmasking of tuberculosis by antiretroviral therapy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3625673

The cost effectiveness of home-based provision of antiretroviral therapy in rural Uganda

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3625673

Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3625673

Costs of providing care for HIV-infected adults in an urban HIV clinic in Soweto, South Africa

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3625673

The outcomes and outpatient costs of different models of antiretroviral treatment delivery in South Africa

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3625673

The cost-effectiveness of antiretroviral treatment in Khayelitsha, South Africa--a primary data analysis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3625673

The changing direct costs of medical care for patients with HIV/AIDS, 1995-2001.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3625673

Cost of medication therapy in ambulatory HIV-infected patients.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3625673

Use and cost of hospital and community service provision for children with HIV infection at an English HIV referral centre

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3625673

Reduction in human immunodeficiency virus patient hospitalizations and nontraumatic mortality after adoption of highly active antiretroviral therapy

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3625673

Opportunities and challenges for HIV care in overlapping HIV and TB epidemics

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3625673

Comparative costs of inpatient care for HIV-infected and uninfected children and adults in Soweto, South Africa

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3625673

Direct costs for the treatment of HIV-infection in a German cohort after the introduction of HAART.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3625673

A cost-effectiveness analysis of changes in therapeutic strategies in the treatment of HIV since 1996

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3625673

The impact of new antiretroic therapeutic schemes on the cost for AIDS treatment in Greece.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3625673

The cost effectiveness of combination antiretroviral therapy for HIV disease.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3625673

Cost effectiveness of highly active antiretroviral therapy in HIV-infected patients. Swiss HIV Cohort Study.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3625673

Incidence and risk factors for the immune reconstitution inflammatory syndrome in HIV patients in South Africa: a prospective study

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3625673

Resource utilization and hospital cost of HIV/AIDS care in Italy in the era of highly active antiretroviral therapy

4 December 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3625673

[Cost effectiveness analysis of highly active antiretroviral therapy in HIV asymptomatic patients]

4 December 2018

1 reference

12 December 2020

The high cost of medical care for patients who present late (CD4<200 cells/muL) with HIV infection

1 reference

12 December 2020

A prospective evaluation of the cost effectiveness of adding lamivudine to zidovudine-containing antiretroviral treatment regimens in HIV infection. European perspective

1 reference

12 December 2020

Impact of protease inhibitors on AIDS-defining events and hospitalizations in 10 French AIDS reference centres. Fédération National des Centres de Lutte contre le SIDA

1 reference

12 December 2020

Cost-Effectiveness of Earlier Initiation of Antiretroviral Therapy for Uninsured HIV-Infected Adults

1 reference

12 December 2020

Assessing the cost-effectiveness of HAART for adults with HIV in England

1 reference

12 December 2020

The cost-effectiveness of highly active antiretroviral therapy, Canada 1991-2001

1 reference

12 December 2020

The Evolving Cost of HIV in South Africa

1 reference

12 December 2020

10.1097/QAI.0B013E31827E8785

Identifiers

DOI

1 reference

16 August 2017

1 reference

16 August 2017

PubMed publication ID

23187948

1 reference